Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites.

Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites.

<h4>Background</h4>Rifaximin is a non-absorbable antibiotic used to prevent relapses of hepatic encephalopathy which may also be a candidate for prophylaxis of spontaneous bacterial peritonitis (SBP).<h4>Aim</h4>To detect the impact of rifaximin on the occurrence and characte...

Full description

Bibliographic Details
Main Authors:	Philipp Lutz, Marijo Parcina, Isabelle Bekeredjian-Ding, Hans Dieter Nischalke, Jacob Nattermann, Tilman Sauerbruch, Achim Hoerauf, Christian P Strassburg, Ulrich Spengler
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24714550/?tool=EBI

Similar Items

Rifaximin plus cefotaxime versus cefotaxime alone in treatment of spontaneous bacterial peritonitis in patients with cirrhosis
by: Asmaa N Mohammad, et al.
Published: (2018-01-01)

Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis C.
by: Bettina Langhans, et al.
Published: (2012-01-01)

Rifaximin: A reasonable alternative for norfloxacin in the prevention of spontaneous bacterial peritonitis in patients with HCV-related liver cirrhosis
by: Mohammed M. Shamseya, et al.
Published: (2016-09-01)

Spontaneous bacterial peritonitis has no effect on the long-term prognosis of cirrhosis patients with ascites
by: Thomas Deleuran, et al.
Published: (2022-07-01)

The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.
by: Hans Dieter Nischalke, et al.
Published: (2011-01-01)

To Study the Incidence, Predictive Factors and Clinical Outcome of Spontaneous Bacterial Peritonitis in Patients of Cirrhosis with Ascites
by: Kavita Paul, et al.
Published: (2015-07-01)

Detection of IGF2BP3, HOXB7, and NEK2 mRNA expression in brush cytology specimens as a new diagnostic tool in patients with biliary strictures.
by: Hans Dieter Nischalke, et al.
Published: (2012-01-01)

Ascitic Interleukin 6 Is Associated with Poor Outcome and Spontaneous Bacterial Peritonitis: A Validation in Critically Ill Patients with Decompensated Cirrhosis
by: Ulrich Mayr, et al.
Published: (2020-09-01)

Validation of a new simple scoring system to predict spontaneous bacterial peritonitis in patients with cirrhosis and ascites
by: Ngoc Cao Huynh, et al.
Published: (2023-08-01)

Influence of the CXCL1 rs4074 A allele on alcohol induced cirrhosis and HCC in patients of European descent.
by: Hans Dieter Nischalke, et al.
Published: (2013-01-01)

Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis
by: R.M. Catarino, et al.
Published: (2005-02-01)

The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C.
by: Marianne Eisenhardt, et al.
Published: (2012-01-01)

Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?
by: Hans Dieter Nischalke, et al.
Published: (2021-12-01)

Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
by: Mattias Mandorfer, et al.
Published: (2014-01-01)

Diagnostic Value of Ascitic Endocan in Spontaneous Bacterial Peritonitis
by: Ibrahim Abd-Elfattah, et al.
Published: (2023-09-01)

Role of ascitic endocan level in diagnosis of spontaneous bacterial peritonitis in patients with cirrhotic ascites
by: WU Xianmei, et al.
Published: (2020-07-01)

Genetic Variation in Angiotensin II Type 1 Receptor Is Linked to Lipid Levels and Hepatic Steatosis in Alcohol-Associated Liver Disease, but Not to Cirrhosis or Hepatocellular Carcinoma
by: Hans Dieter Nischalke, et al.
Published: (2024-01-01)

Ascitic Fluid High Sensitive C-Reactive Protein (hs-CRP). A Prognostic Marker in Cirrhosis with Spontaneous Bacterial Peritonitis
by: Nakul Kadam, et al.
Published: (2016-04-01)

Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-Series
by: Nina Kimer, et al.
Published: (2020-10-01)

Reappraisal of the Role of Ascitic Fluid Adenosine Deaminase for the Diagnosis of Peritoneal Tuberculosis in Cirrhosis
by: Amol Sonyabapu Dahale, et al.
Published: (2021-09-01)

Helminth antigens differentially modulate the activation of CD4+ and CD8+ T lymphocytes of convalescent COVID-19 patients in vitro
by: Tomabu Adjobimey, et al.
Published: (2022-06-01)

EVALUATION OF EFFICACY OF RIFAXIMIN IN THE TREATMENT OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS
by: Hafsa Habib, et al.
Published: (2016-12-01)

Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension.
by: Jonel Trebicka, et al.
Published: (2013-01-01)

Rifaximin plus norfloxacin versus norfloxacin alone in primary prophylaxis of spontaneous bacterial peritonitis in patients with variceal bleeding
by: Ahmed A Ghafar, et al.
Published: (2019-01-01)

Do we see spontaneous bacterial peritonitis in patients with malignant ascites?
by: Alfonso Javier Tafur, et al.
Published: (2005-01-01)

Spontaneous bacterial peritonitis complicating ovarian hyperstimulation syndrome-related ascites
by: Leandro Utino Taniguchi, et al.
Published: (2011-01-01)

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
by: Elisa Pose, et al.
Published: (2022-05-01)

ESBL Detection: Comparison of a Commercially Available Chromogenic Test for Third Generation Cephalosporine Resistance and Automated Susceptibility Testing in Enterobactericeae.
by: Mohamed Ramadan El-Jade, et al.
Published: (2016-01-01)

Impact of spontaneous bacterial peritonitis on the outcome of patients with cirrhosis
by: Sandra Teutli-Carrión, et al.
Published: (2024-02-01)

Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis
by: Angelo A. Mattos, et al.
Published: (2020-09-01)

A Case of Hydrothorax Aggravated by Peritoneal Dialysate Leakage in Compensated Liver Cirrhosis Patient with Ascites
by: Gain You, et al.
Published: (2014-06-01)

Bacterial growth and ceftriaxone activity in individual ascitic fluids in an in vitro model of spontaneous bacterial peritonitis
by: Wisse van Os, et al.
Published: (2023-03-01)

TRAIL receptor I (<it>DR4</it>) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients
by: Körner Christian, et al.
Published: (2012-03-01)

Ascitic fluid calprotectin and ratio of calprotectin to total protein in spontaneous bacterial peritonitis
by: Mai Mustafa Fahmy, et al.
Published: (2023-05-01)

Serum and ascitic procalcitonin as a marker for early diagnosis of spontaneous bacterial peritonitis
by: Elsayed I Elshayeb, et al.
Published: (2019-01-01)

Ascites and spontaneous bacterial peritonitis: Recommendations from two United States centers
by: Vinay Sundaram, et al.
Published: (2014-01-01)

Ascites, spontaneous bacterial peritonitis, hepatorenal syndrome: What is common in their diagnosis and treatment?
by: I G Bakulin, et al.
Published: (2015-04-01)

Diagnostic Accuracy of Ascites Fluid Gross Appearance in Detection of Spontaneous Bacterial Peritonitis
by: Hamed Aminiahidashti, et al.
Published: (2014-07-01)

Diagnostic Accuracy of Ascites Fluid Gross Appearance in Detection of Spontaneous Bacterial Peritonitis
by: Hamed Aminiahidashti, et al.
Published: (2014-08-01)

Coinheritance of hereditary spherocytosis and reversibility of cirrhosis in a young female patient with hereditary hemochromatosis
by: Höblinger A, et al.
Published: (2009-04-01)